Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GYRE THERAPEUTICS, INC. has filed 1,598 SEC EDGAR filings since 16 Dec 2002

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
4

FORM 4 - STEPHEN A. HILL

Filing date
24 Jan 2014
Reporting date
23 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
17 Jan 2014
Reporting date
08 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Jan 2014
Reporting date
08 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
16 Dec 2013
Reporting date
16 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-192552

PROSPECTUS

Filing date
12 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-192552

PROSPECTUS

Filing date
12 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-192552

EFFECT filing

Filing date
11 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Dec 2013
Reporting date
05 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Dec 2013
Reporting date
05 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Dec 2013
Reporting date
03 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
26 Nov 2013
Reporting date
26 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-192552

FORM S-3

Filing date
26 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2013
Reporting date
21 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2013
Reporting date
21 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2013
Reporting date
21 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
14 Nov 2013
Reporting date
11 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
05 Nov 2013
Reporting date
05 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Oct 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Oct 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82442

SC 13G/A filing

Filing date
10 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
14 Aug 2013
Reporting date
13 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
06 Aug 2013
Reporting date
06 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-115538

CT ORDER filing

Filing date
02 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .